World Health Organization Workshop on Plague Vaccine Evaluation

An official website of the United States government

Here's how you know

Official websites use .mil

A .mil website belongs to an official U.S. Department of Defense organization in the United States.

Secure .mil websites use HTTPS

A lock () or https:// means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.

JPEO-CBRND Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense

JPEO-CBRND

Search Joint Program Executive Office for Chemical, Biological Defense (JPEO-CBRND):

Dr. Lucy Ward, Senior Scientist for the Joint Vaccine Acquisition Program (JVAP) product management office under the Joint Project Manager for Medical Countermeasure Systems (JPM-MCS) participated in a panel discussion on April 23, 2018 on JVAP's advanced development of a vaccine to protect against plague. The World Health Organization hosted the Workshop on Plague Vaccine Evaluation in Paris, France to discuss recent trends in plague vaccine development. JVAP develops, produces, and fields Food and Drug Administration-licensed biological defense vaccines. JPM-MCS is one of the five JPMs under the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense.

2018April23_MCSJVAP_rF1VVaccine_WHO_Panel version

News Search

News Archive - Search by Year and Month

2024 (15)
2023 (36)
2022 (30)
2021 (37)
2020 (15)
2019 (11)
2018 (5)
2017 (9)
2016 (1)

JPEO-CBRND Press Kit

Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the JPEO-CBRND's Capabilities Catalog, Leadership Biographies, COVID-19 fact sheets, and contracting overview documents.

JPEO-CBRND Public Affairs Office

The JPEO-CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the JPEO-CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.